Evaluating the role of HLA-DQ polymorphisms on immune response to bacterial superantigens using transgenic mice.

Bacterial superantigens bind directly to human leukocyte antigen (HLA) class II molecules and vigorously activate T cells expressing certain T-cell receptor variable region families. As interaction with HLA class II molecules is the primary step in this process, polymorphic variations in HLA class II can determine the extent of superantigen binding to HLA class II molecules, govern the magnitude of immune activation induced by given superantigens and determine the outcome of superantigen-mediated diseases. As direct assessment of the influence of HLA class II polymorphism in humans is impossible because of expression of more than one HLA class II alleles in a given individual and toxicity of superantigens, transgenic mice expressing HLA-DQ6 (HLA-DQA1*0103 and HLA-DQB1*0601) and HLA-DQ8 (HLA-DQA1*0301 and HLA-DQB1*0302) were used to achieve this goal. HLA-DQ6 and HLA-DQ8 elicited comparable in vitro and in vivo immune response to staphylococcal enterotoxins (SE) A, SEB, SEH and SEK, toxic shock syndrome toxin-1, streptococcal pyrogenic exotoxin (SPE) A and SPEC and streptococcal mitogenic exotoxin Z (SMEZ). However, each superantigen had a unique T-cell receptor activation profile. In vivo challenge with Streptococcus pyogenes, H305, capable of elaborating SPEA and SMEZ, yielded a similar clinical outcome in HLA-DQ6 and HLA-DQ8 transgenic mice. In conclusion, HLA-DQ6 and HLA-DQ8 elicited comparable response to certain bacterial superantigens. Our report highlights the advantages of HLA class II transgenic mice in such studies.

[1]  Robin Patel,et al.  Acute systemic immune activation following vaginal exposure to staphylococcal enterotoxin B--implications for menstrual shock. , 2007, Journal of reproductive immunology.

[2]  Robin Patel,et al.  INTRANASAL EXPOSURE TO STAPHYLOCOCCAL ENTEROTOXIN B ELICITS AN ACUTE SYSTEMIC INFLAMMATORY RESPONSE , 2006, Shock.

[3]  Gregory A Poland,et al.  Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine. , 2006, The Journal of infectious diseases.

[4]  K. Nath,et al.  Endogenous Superantigens Shape Response to Exogenous Superantigens , 2005, Clinical Diagnostic Laboratory Immunology.

[5]  G. Ruthel,et al.  Persistence of Zinc-Binding Bacterial Superantigens at the Surface of Antigen-Presenting Cells Contributes to the Extreme Potency of These Superantigens as T-Cell Activators , 2005, Infection and Immunity.

[6]  D. Monos,et al.  Identification of HLA-DQα and -DRβ residues associated with susceptibility and protection to epithelial ovarian cancer , 2005 .

[7]  G. Rajagopalan,et al.  In Vitro and In Vivo Evaluation of Staphylococcal Superantigen Peptide Antagonists , 2004, Infection and Immunity.

[8]  K. Acharya,et al.  Crystal structure of a dimeric form of streptococcal pyrogenic exotoxin A (SpeA1) , 2004, Protein science : a publication of the Protein Society.

[9]  D. Turner.  ES07.02 
The human leucocyte antigen (HLA) system , 2004 .

[10]  A. Agadir,et al.  Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. , 2004, Clinical immunology.

[11]  D. Douek,et al.  HLA Class II Polymorphisms Determine Responses to Bacterial Superantigens1 , 2004, The Journal of Immunology.

[12]  C. David,et al.  Characterization of HLA DR2 and DQ8 transgenic mouse with a new engineered mouse class II deletion, which lacks all endogenous class II genes. , 2003, Journal of autoimmunity.

[13]  Q. Wan,et al.  HLA and H2 Class II Transgenic Mouse Models to Study Susceptibility and Protection in Autoimmune Thyroid Disease , 2003, Autoimmunity.

[14]  G. Rajagopalan,et al.  Expression and function of HLA-DR3 and DQ8 in transgenic mice lacking functional H2-M. , 2003, Tissue antigens.

[15]  A. Lew,et al.  Without peripheral interference, thymic deletion is mediated in a cohort of double-positive cells without classical activation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Malak Kotb,et al.  An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections , 2002, Nature Medicine.

[17]  John D. Fraser,et al.  The Bacterial Superantigen Streptococcal Mitogenic Exotoxin Z Is the Major Immunoactive Agent of Streptococcus pyogenes1 , 2002, The Journal of Immunology.

[18]  A. Norrby-Teglund,et al.  Differential presentation of group A streptococcal superantigens by HLA class II DQ and DR alleles , 2002, European journal of immunology.

[19]  M. Aman,et al.  Lethal shock induced by streptococcal pyrogenic exotoxin A in mice transgenic for human leukocyte antigen-DQ8 and human CD4 receptors: implications for development of vaccines and therapeutics. , 2002, The Journal of infectious diseases.

[20]  J. Brewer,et al.  Thymocyte Apoptosis Induced by T Cell Activation Is Mediated by Glucocorticoids In Vivo1 , 2002, The Journal of Immunology.

[21]  G. Rajagopalan,et al.  Expression and Function of Transgenic HLA-DQ Molecules and Lymphocyte Development in Mice Lacking Invariant Chain1 , 2002, The Journal of Immunology.

[22]  E. Marietta,et al.  Staphylococcal enterotoxin B-induced activation and concomitant resistance to cell death in CD28-deficient HLA-DQ8 transgenic mice. , 2002, International immunology.

[23]  J. Madsen,et al.  Toxins as weapons of mass destruction. A comparison and contrast with biological-warfare and chemical-warfare agents. , 2001, Clinics in laboratory medicine.

[24]  D. Altmann,et al.  Enhanced susceptibility to superantigen-associated streptococcal sepsis in human leukocyte antigen-DQ transgenic mice. , 2001, The Journal of infectious diseases.

[25]  K. Acharya,et al.  Structural features of a zinc binding site in the superantigen strepococcal pyrogenic exotoxin A (SpeA1): Implications for MHC class II recognition , 2001, Protein science : a publication of the Protein Society.

[26]  C. David,et al.  Identification of HLA-class-II-restricted epitopes of autoantigens in transgenic mice. , 2000, Current opinion in immunology.

[27]  C. Benoist,et al.  Mice lacking all conventional MHC class II genes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[28]  V. Taneja,et al.  HLA class II transgenic mice as models of human diseases , 1999, Immunological reviews.

[29]  T. Jardetzky,et al.  Structural basis for HLA–DQ binding by the streptococcal superantigen SSA , 1999, Nature Structural Biology.

[30]  J. Sprent,et al.  A Role for Fas in Negative Selection of Thymocytes In Vivo , 1998, The Journal of experimental medicine.

[31]  Kirchner,et al.  Cytokine Induction by Mycoplasma arthritidis‐Derived Superantigen (MAS), but not by TSST‐1 or SEC‐3, is Correlated to Certain HLA‐DR Types , 1998, Scandinavian journal of immunology.

[32]  M. A. Olson,et al.  Molecular docking of superantigens with class II major histocompatibility complex proteins , 1997, Journal of molecular recognition : JMR.

[33]  A. Sawitzke,et al.  Allelic polymorphisms at the H-2A and HLA-DQ loci influence the response of murine lymphocytes to the Mycoplasma arthritidis superantigen MAM , 1997 .

[34]  Don C. Wiley,et al.  Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen , 1994, Nature.

[35]  H. Inoko,et al.  Human HLA-DQβ chain presents minor lymphocyte stimulating locus gene products and clonally deletes TCR Vβ6+, Vβ8.1+ T cells in single transgenic mice , 1991 .

[36]  H. Inoko,et al.  Thymic deletion of V beta 11+, V beta 5+ T cells in H-2E negative, HLA-DQ beta+ single transgenic mice. , 1991, Journal of immunology.

[37]  H. Inoko,et al.  Relative activities of distinct isotypes of murine and human major histocompatibility complex class II molecules in binding toxic shock syndrome toxin 1 and determination of CD antigens expressed on T cells generated upon stimulation by the toxin , 1990, Infection and immunity.

[38]  R. Karr,et al.  Effect of isotypes and allelic polymorphism on the binding of staphylococcal exotoxins to MHC class II molecules. , 1990, Journal of immunology.

[39]  H. Macdonald,et al.  Different staphylococcal enterotoxins bind preferentially to distinct major histocompatibility complex class ii isotypes , 1989, European journal of immunology.

[40]  R. Geha,et al.  Staphylococcal enterotoxin B and toxic shock syndrome toxin-1 bind to distinct sites on HLA-DR and HLA-DQ molecules. , 1989, Journal of immunology.

[41]  H. Mcdevitt,et al.  Structure and Polymorphism of Murine and Human Class II Major Histocompatibility Antigens , 1985, Immunological reviews.

[42]  W. Reith,et al.  The bare lymphocyte syndrome and the regulation of MHC expression. , 2001, Annual review of immunology.

[43]  J. McCormick,et al.  Toxic shock syndrome and bacterial superantigens: an update. , 2001, Annual review of microbiology.

[44]  D. Ohlendorf,et al.  Structure of streptococcal pyrogenic exotoxin A reveals a novel metal cluster , 2000, Protein science : a publication of the Protein Society.

[45]  F. Cockerill,et al.  Lack of benefit of intravenous immune globulin in a murine model of group A streptococcal necrotizing fasciitis. , 2000, The Journal of infectious diseases.

[46]  A. Llera,et al.  The structural basis of T cell activation by superantigens. , 1999, Annual review of immunology.

[47]  A. Hill,et al.  The immunogenetics of human infectious diseases. , 1998, Annual review of immunology.